It has been reported that β-escin induces cancer cell death through the mitochondrial caspase dependent pathway [41], inhibition of NF-κB signalling [36, 38] and GSK3β/β-catenin pathway [40] indicating that the mechanism of action may be cell type dependent. Here, GSK3B is linked to cancer.